These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 22072847)

  • 1. Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.
    Bradford K; Shih DQ
    World J Gastroenterol; 2011 Oct; 17(37):4166-73. PubMed ID: 22072847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.
    Amin J; Huang B; Yoon J; Shih DQ
    Inflamm Bowel Dis; 2015 Feb; 21(2):445-52. PubMed ID: 25248004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
    Teml A; Schaeffeler E; Herrlinger KR; Klotz U; Schwab M
    Clin Pharmacokinet; 2007; 46(3):187-208. PubMed ID: 17328579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing treatment with thioguanine derivatives in inflammatory bowel disease.
    Louis E; Belaiche J
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):37-46. PubMed ID: 12617881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
    Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
    Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism.
    Shih DQ; Nguyen M; Zheng L; Ibanez P; Mei L; Kwan LY; Bradford K; Ting C; Targan SR; Vasiliauskas EA
    Aliment Pharmacol Ther; 2012 Sep; 36(5):449-58. PubMed ID: 22784257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM; Ng JF; Dowling D
    Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing immunomodulator therapy for inflammatory bowel disease.
    Dubinsky MC
    Curr Gastroenterol Rep; 2003 Dec; 5(6):506-11. PubMed ID: 14602061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
    Sparrow MP; Hande SA; Friedman S; Cao D; Hanauer SB
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):209-14. PubMed ID: 17296529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
    Armstrong L; Sharif JA; Galloway P; McGrogan P; Bishop J; Russell RK
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
    Wall GC; Muktar H; Effken C; Mahajan PB
    Pharmacotherapy; 2018 Feb; 38(2):259-270. PubMed ID: 29197117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of measuring 6-methylmercaptopurine and 6-thioguanine nucleotide levels in managing inflammatory bowel disease patients treated with 6-mercaptopurine in a clinical practice setting.
    Mardini HE; Arnold GL
    J Clin Gastroenterol; 2003; 36(5):390-5. PubMed ID: 12702978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease].
    Gisbert JP; González-Lama Y; Maté J
    Gastroenterol Hepatol; 2006 Nov; 29(9):568-83. PubMed ID: 17129552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Spencer E; Norris E; Williams C; Dubinsky MC
    Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing thiopurine therapy in inflammatory bowel disease.
    Chevaux JB; Peyrin-Biroulet L; Sparrow MP
    Inflamm Bowel Dis; 2011 Jun; 17(6):1428-35. PubMed ID: 20949566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
    Hoentjen F; Seinen ML; Hanauer SB; de Boer NK; Rubin DT; Bouma G; Harrell LE; van Bodegraven AA
    Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases.
    Serpico MR; Maltz R; Crandall W; Bricker J; Dotson JL; Kim SC; Boyle B
    J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):341-345. PubMed ID: 29601433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.